Competing or Complementary?:Ethical Considerations and the Quality of Randomized Trials
- 1 January 1996
- journal article
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 12 (2), 247-263
- https://doi.org/10.1017/s0266462300009600
Abstract
The ethical principles of beneficence (doing the best for one's patients and clients), nonmaleficence (doing no harm), autonomy, justice, and equity, are positively associated with the quality of a trial rather than being opposed to it. Ethical considerations involve such important questions as appropriate design and documentation, participation rates, withdrawals or losses to follow-up, careful monitoring of safety and efficacy, timely completion, generalizability, and publication and dissemination of findings. When conflicts between ethical considerations and the trial's scientific quality do occur, the ethical considerations must be paramount.Keywords
This publication has 94 references indexed in Scilit:
- From clinical trials to clinical practice: Generalizing from participant to patientControlled Clinical Trials, 1994
- Ethical, behavioral, and social aspects of HIV vaccine trials in developing countriesPublished by American Medical Association (AMA) ,1994
- Politically correct clinical trialsControlled Clinical Trials, 1993
- Directive to the director of NIH from the membership of the society for clinical trialsControlled Clinical Trials, 1993
- A Randomized Study of Two Methods of Teaching Perineal Massage: Effects on Practice Rates, Episiotomy Rates, and LacerationsBirth, 1991
- THE RIGHTS OF THE PATIENT IN CLINICAL RESEARCHThe Lancet, 1988
- Are the Results of the Extracranial–Intracranial Bypass Trial Generalizable?New England Journal of Medicine, 1987
- Patients’ Preferences in Randomized Clinical TrialsNew England Journal of Medicine, 1984
- Physicians’ Reasons for Not Entering Eligible Patients in a Randomized Clinical Trial of Surgery for Breast CancerNew England Journal of Medicine, 1984
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979